Henlius Maintains Stable Share Capital in March; Confirms Public-Float Compliance

Bulletin Express04-08 18:43

Shanghai Henlius Biotech, Inc. (Henlius) filed its Monthly Return for Equity Issuer covering March 2026, reporting no changes in either authorised or issued share capital.

Key Takeaways

• Share capital unchanged – Authorised/registered capital remained at 543.49 million ordinary shares (par value: RMB 1.00 each), comprising 346.07 million H shares listed in Hong Kong and 197.42 million unlisted shares. – Issued H shares were flat at 346.07 million; the company held no treasury shares.

• Public-float requirement met Henlius confirmed compliance with the Hong Kong Main Board’s minimum float threshold of 18.77% for its H shares as at 31 March 2026.

• Equity incentive plans saw limited activity – 2025 H Share Option Scheme: 10,000 options lapsed, reducing outstanding options to 6.99 million; no new shares were issued and no treasury shares were transferred. – 2025 H Share RSU Scheme: 10,000 RSUs lapsed during the month; 7.01 million RSUs remain outstanding with no share issuances or treasury share movements.

• No warrants, convertibles, or other equity-linked instruments were exercised or issued during the period.

Overall, Henlius reported a static equity structure for March 2026, with incentive-plan adjustments exerting no impact on share count or capital structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182497551?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-08 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182497551","market":"hk","top_or_hot":-1,"title":"Henlius Maintains Stable Share Capital in March; Confirms Public-Float Compliance","media":"Bulletin Express","content":"<p>Shanghai Henlius Biotech, Inc. (Henlius) filed its Monthly Return for Equity Issuer covering March 2026, reporting no changes in either authorised or issued share capital.</p>\n<p>Key Takeaways</p>\n<p>• Share capital unchanged  \n– Authorised/registered capital remained at 543.49 million ordinary shares (par value: RMB 1.00 each), comprising 346.07 million H shares listed in Hong Kong and 197.42 million unlisted shares.  \n– Issued H shares were flat at 346.07 million; the company held no treasury shares.</p>\n<p>• Public-float requirement met  \nHenlius confirmed compliance with the Hong Kong Main Board’s minimum float threshold of 18.77% for its H shares as at 31 March 2026.</p>\n<p>• Equity incentive plans saw limited activity  \n– 2025 H Share Option Scheme: 10,000 options lapsed, reducing outstanding options to 6.99 million; no new shares were issued and no treasury shares were transferred.  \n– 2025 H Share RSU Scheme: 10,000 RSUs lapsed during the month; 7.01 million RSUs remain outstanding with no share issuances or treasury share movements.</p>\n<p>• No warrants, convertibles, or other equity-linked instruments were exercised or issued during the period.</p>\n<p>Overall, Henlius reported a static equity structure for March 2026, with incentive-plan adjustments exerting no impact on share count or capital structure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Henlius Maintains Stable Share Capital in March; Confirms Public-Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHenlius Maintains Stable Share Capital in March; Confirms Public-Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-08 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Henlius Biotech, Inc. (Henlius) filed its Monthly Return for Equity Issuer covering March 2026, reporting no changes in either authorised or issued share capital.</p>\n<p>Key Takeaways</p>\n<p>• Share capital unchanged  \n– Authorised/registered capital remained at 543.49 million ordinary shares (par value: RMB 1.00 each), comprising 346.07 million H shares listed in Hong Kong and 197.42 million unlisted shares.  \n– Issued H shares were flat at 346.07 million; the company held no treasury shares.</p>\n<p>• Public-float requirement met  \nHenlius confirmed compliance with the Hong Kong Main Board’s minimum float threshold of 18.77% for its H shares as at 31 March 2026.</p>\n<p>• Equity incentive plans saw limited activity  \n– 2025 H Share Option Scheme: 10,000 options lapsed, reducing outstanding options to 6.99 million; no new shares were issued and no treasury shares were transferred.  \n– 2025 H Share RSU Scheme: 10,000 RSUs lapsed during the month; 7.01 million RSUs remain outstanding with no share issuances or treasury share movements.</p>\n<p>• No warrants, convertibles, or other equity-linked instruments were exercised or issued during the period.</p>\n<p>Overall, Henlius reported a static equity structure for March 2026, with incentive-plan adjustments exerting no impact on share count or capital structure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02696","symbol_name":"复宏汉霖","start_time":0,"source_url":"","article_id":"1182497551","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182497551","pubTimestamp":1775645016,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Henlius Biotech, Inc. (Henlius) filed its Monthly Return for Equity Issuer covering March 2026, reporting no changes in either authorised or issued share capital. Key Takeaways • Share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02696":"复宏汉霖"},"translate_title":"复宏汉霖3月股本保持稳定；确认公众持股合规性","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1},"content_text":"Shanghai Henlius Biotech, Inc. (Henlius) filed its Monthly Return for Equity Issuer covering March 2026, reporting no changes in either authorised or issued share capital.\nKey Takeaways\n• Share capital unchanged  \n– Authorised/registered capital remained at 543.49 million ordinary shares (par value: RMB 1.00 each), comprising 346.07 million H shares listed in Hong Kong and 197.42 million unlisted shares.  \n– Issued H shares were flat at 346.07 million; the company held no treasury shares.\n• Public-float requirement met  \nHenlius confirmed compliance with the Hong Kong Main Board’s minimum float threshold of 18.77% for its H shares as at 31 March 2026.\n• Equity incentive plans saw limited activity  \n– 2025 H Share Option Scheme: 10,000 options lapsed, reducing outstanding options to 6.99 million; no new shares were issued and no treasury shares were transferred.  \n– 2025 H Share RSU Scheme: 10,000 RSUs lapsed during the month; 7.01 million RSUs remain outstanding with no share issuances or treasury share movements.\n• No warrants, convertibles, or other equity-linked instruments were exercised or issued during the period.\nOverall, Henlius reported a static equity structure for March 2026, with incentive-plan adjustments exerting no impact on share count or capital structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182497551","isCrawlerRequest":true}